Takeshita et al.33tested ESR1 mutations (E380Q, Y537S, Y537N, Y537C and D538G) of tumour tissue and plasma cell‐free DNA (cfDNA) in 62 patients and found that 21% of patients with advanced breast cancer have ESR1 mutations. Here, ESR1 is linked to breast carcinoma.